Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

Poolbeg announces strategic expansion of POLB 001 into oncology

January 16, 2023 Business Services

16 January 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading infectious disease focused biopharmaceutical …
News
Press release

finnCap Cavendish advises on the sale of MBI Healthcare Technologies to DNV

January 13, 2023 Business Services

London, 9th January – finnCap Cavendish, part of finnCap Group plc, is pleased to announce it has advised the three …
News
Press release

Avillion announces US approval of AstraZeneca’s Airsupra (PT027) as new rescue treatment for asthma

January 11, 2023 Business Services

London, UK, 11 January 2023 – Avillion LLP, a drug development company focused on the co-development and financing of pharmaceutical …
News
Press release

Ovarian Cancer Commitment launches digital patient support resource for anyone affected by ovarian cancer

January 11, 2023 Business Services

28 October 2022, 10:00 BST
News
Press release

New technology to “unlock” NHS records to revolutionise how we take medicine

January 11, 2023 Business Services

London, UK – New technology which can “unlock” medication records has been awarded £1m in fresh funding by Innovate UK.
News
Press release

STORM Therapeutics Expands R&D Leadership Team

January 10, 2023 Business Services

10 January 2023, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the clinical stage biotechnology company discovering and developing novel small molecule …
News
Press release

Positive Initial Data Analysis in POLB 001 LPS Challenge Trial

January 9, 2023 Business Services

9 January 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading infectious disease focused biopharmaceutical …
News
Press release

Novo Holdings invests in proteomics technology company, Evosep

January 9, 2023 Business Services

The proceeds from the investment by Novo Holdings will be used to advance clinical applications of proteomics enabled by Evosep’s …
News
Press release

James Noble

January 6, 2023 Business Services

St Andrews, UK – 6 January 2023 – Pneumagen, a clinical stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal …
Appointment

Transgene Receives Approval to Start a Phase I Trial of TG6050, a Novel IL-12-Armed Oncolytic Virus Given by Intravenous Administration

January 6, 2023 Business Services

Strasbourg, France, January 6, 2023, 7:30 a.m.
News
Press release

Nouscom Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate NOUS-209 in combination with KEYTRUDA® (pembrolizumab) in a Phase 2 Randomized Trials in dMMR/MSI-High Metastatic Colorectal Cancer

January 5, 2023 Business Services

BASEL, Switzerland – 5th January 2023 – Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized immunotherapies, today announced …
News
Press release

Lidia Oostvogels

January 5, 2023 Business Services

MinervaX appoints Lidia Oostvogels as Chief Medical Officer and provides clinical and regulatory update on its novel GBS vaccine
Appointment

iOnctura provides development update on first-in-class semi-allosteric PI3Kδ inhibitor program

January 5, 2023 Business Services

Geneva, Switzerland and Amsterdam, The Netherlands, 5 January – iOnctura, a clinical-stage biotech developing selective cancer therapies against targets that …
News
Press release

Adcendo ApS Announces License Agreement with Duality Biologics on Next-generation ADC Platform

January 5, 2023 Business Services

Copenhagen, Denmark, January 5, 2023 – Adcendo ApS (“Adcendo”), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) …
News
Press release

Sosei Heptares Notes its Partner Tempero Bio has Received FDA Clearance to Advance Clinical Development of TMP-301 for Treatment of Alcohol and Substance Use Disorders

January 5, 2023 Business Services

Tokyo, Japan and Cambridge, UK, 5 January 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …
News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025